Bridion works by selectively binding to the neuromuscular blocking agents, such as rocuronium or vecuronium, forming a complex that is then excreted by the kidneys. This process effectively reverses the muscle relaxation caused by the neuromuscular blocking agents, allowing patients to regain normal muscle function more rapidly.